Stockscreener 앱 받기
1.035
2.42%
-0.0257
시간 외 거래:
1.09
0.055
+5.31%
Okyo Pharma Limited 주식(OKYO)의 최신 뉴스
OKYO Pharma executive chairman increases stake - Investing.com
OKYO Pharma executive increases stake in company By Investing.com - Investing.com Australia
OKYO Pharma executive chairman increases stake By Investing.com - Investing.com UK
OKYO Pharma executive increases stake in company - Investing.com
OKYO Pharma executive increases stake in company By Investing.com - Investing.com Canada
OKYO Pharma Chairman Boosts Stake, Advances Trials - TipRanks
Okyo Pharma announces acquisition of shares by chairman - TipRanks
OKYO Pharma Announces Chairman Acquires Shares - GlobeNewswire
OKYO Pharma chair increases shareholdings - Proactive Investors USA
OKYO Pharma Announces Chairman Acquires Shares - Yahoo Finance UK
OKYO Pharma Announces Chairman Acquires Shares - Informazione.it
OKYO Pharma executive increases stake - Investing.com
OKYO Pharma Ltd expected to post a loss of 11 cents a shareEarnings Preview - XM
OKYO Pharma executive increases stake By Investing.com - Investing.com Canada
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease - Yahoo Finance UK
OKYO Pharma executive increases stake - Investing.com India
OKYO Pharma executive increases stake By Investing.com - Investing.com UK
OKYO Pharma executive increases stake in company By Investing.com - Investing.com UK
OKYO Pharma (NASDAQ:OKYO) & Moderna (NASDAQ:MRNA) Financial Analysis - Defense World
OKYO Pharma stock poised for potential gains ahead of Phase 2b dataH.C. Wainwright - Investing.com
OKYO Pharma (NASDAQ:OKYO) Receives Buy Rating from HC Wainwright - Defense World
OKYO Pharma (LON:OKYO) Trading Down 24.3% - Defense World
OKYO Pharma secures US patent for dry eye disease therapy - Investing.com
OKYO Pharma secures key US patent for dry eye disease treatment - Investing.com
OKYO Pharma Secures U.S. Patent for DED Therapy - TipRanks
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease - GlobeNewswire
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease - StockTitan
OKYO Pharma secures key US patent for dry eye disease therapy - Proactive Investors UK
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease - Yahoo Finance
OKYO Pharma Exec Chairman Increases Stake - Investing.com India
The Significance of Moving Averages in OKYO Pharma Limited Inc. (OKYO) Price Performance - The InvestChronicle
OKYO Pharma Exec Chairman Increases Stake By Investing.com - Investing.com Canada
OKYO Pharma Exec Chairman Increases Stake By Investing.com - Investing.com Australia
OKYO Pharma CEO Interview to Air on Bloomberg TV - Yahoo Finance UK
OKYO Pharma Advances in Ocular Disease Therapies - TipRanks
OKYO Pharma and SolarMax Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
OKYO Pharma CEO Interview to Air on Bloomberg TV - GlobeNewswire
OKYO Pharma and SolarMax Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - StockTitan
OKYO Pharma Exec Chairman Increases Stake - Investing.com
OKYO Pharma Exec Chairman Increases Stake By Investing.com - Investing.com UK
OKYO Pharma Chairman Buys More Shares - TipRanks
OKYO Pharma CEO Interview to Air on Bloomberg TV - Informazione.it
OKYO Pharma executive chairman increases stake By Investing.com - Investing.com Australia
OKYO Pharma chairman acquires more shares in the company - Proactive Investors USA
OKYO Pharma Chairman Boosts Shareholding - TipRanks
OKYO Pharma Announces Chairman Acquires Shares - StockTitan
OKYO Pharma to present at ophthalmology conference By Investing.com - Investing.com Australia
OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - Marketscreener.com
OKYO Pharma Showcases OK-101 at Ophthalmology Conference - TipRanks
OKYO Pharma to present at ophthalmology conference - Investing.com
OKYO Pharma to participate in virtual ophthalmology conference - Proactive Investors UK
OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - GlobeNewswire
OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - StockTitan
0.87%
1.31%
자본화:
|
볼륨(24시간):